https://www.bioworld.com/rss en-us BioWorld tracked 209 clinical trial readouts across phases I through III in March 2026, up from 152 in February and 144 in January. Among late-stage programs, 26 phase III trials reported positive results, two produced mixed results, and three failed to meet key endpoints. By phase, March updates included 62 from phase I, 74 from phase II and 73 phase III.]]> http://www.bioworld.com/articles/730620 Fri, 24 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730620-xenon-spikes-theravance-sinks-after-phase-iii-readouts-in-march Health professional pointing stethoscope at Clinical Trial words, icons http://www.bioworld.com/articles/730500 Wed, 22 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730500-akeso-sets-durability-bar-as-immuno-oncology-20-race-heats-up Pancreas anatomy illustration http://www.bioworld.com/articles/730499 Wed, 22 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730499-netrin-1-inhibitor-blocks-chemo-resistance-in-pancreatic-cancer Health care worker with IV drip http://www.bioworld.com/articles/730496 Wed, 22 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730496-revolution-rocks-on-with-first-line-pdac-data-at-aacr Targeted cancer cell http://www.bioworld.com/articles/730495 Wed, 22 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730495-walking-the-talk-kyverna-phase-ii-stiffens-miv-cel-car-t-case Woman stretching her arms and hands http://www.bioworld.com/articles/730581 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730581-delta-fly-eyes-nda-path-despite-aml-phase-iii-miss Acute myeloid leukemia illustration http://www.bioworld.com/articles/730579 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730579-xuanzhu-shares-dip-despite-phase-iii-alk-inhibitor-data Lung cancer illustration BioWorld. Remedy is taking a secretome-based approach to treat lung disorders, having moved its lead asset, RC-0315, into a first-in-human clinical trial for idiopathic pulmonary fibrosis (IPF) in January. ]]> http://www.bioworld.com/articles/730576 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730576-remedy-pushes-cell-free-secretome-therapy-for-ipf-into-phase-i Ayele Dilion Mashiah, CEO, Remedy Ayelet Dilion Mashiah, CEO, Remedy Cell Ltd. http://www.bioworld.com/articles/730486 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730486-early-data-position-junshi-in-next-gen-immuno-oncology-race Illustration of cancer cells and immunotherapy treatment http://www.bioworld.com/articles/730483 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730483-xeltis-secures-ce-mark-for-axess-its-hemodialysis-conduit Xeltis-Axess-vascular-access-conduit-8jan25jpg.jpg Axess vascular access conduit. Credit: Xeltis BV http://www.bioworld.com/articles/730481 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730481-nektars-rezpeg-more-than-worth-its-salt-in-alopecia-phase-iib Hand showing bald patch of scalp http://www.bioworld.com/articles/730470 Mon, 20 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730470-xuanzhu-shares-dip-despite-phase-iii-alk-inhibitor-data Lung cancer illustration http://www.bioworld.com/articles/730468 Mon, 20 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730468-novos-forma-acquisition-pays-off-with-mitapivat-competitor Sickle cell illustration http://www.bioworld.com/articles/730466 Mon, 20 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730466-aiming-to-jimi-the-regulatory-lock-in-psychedelics Pills shaded in psychedelic colors http://www.bioworld.com/articles/730406 Fri, 17 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730406-delta-fly-eyes-nda-path-despite-aml-phase-iii-miss Acute myeloid leukemia illustration Nature Communications Medicine. The platform, which combines AI-driven image analysis and physics-based computational modeling, demonstrated strong agreement with in vivo imaging data across multiple inhalation scenarios. ]]> http://www.bioworld.com/articles/730405 Fri, 17 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730405-ebenbuilds-tech-for-predicting-lung-drug-deposition-validated Ebenbuild Lung digital twin with aerosol particles Lung digital twin with aerosol particles. Credit: Ebenbuild GmbH http://www.bioworld.com/articles/730389 Thu, 16 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730389-lillys-glp-1-foundayo-aces-mace-in-dili-of-a-phase-iii Foundayo Credit: Eli Lilly and Co. BioWorld. Remedy is taking a secretome-based approach to treat lung disorders, having moved its lead asset, RC-0315, into a first-in-human clinical trial for idiopathic pulmonary fibrosis (IPF) in January. Secretomes refer to the collection of bioactive molecules secreted by cells in the extracellular space, including proteins, enzymes, growth factors and extracellular vesicles such as exosomes.]]> http://www.bioworld.com/articles/730310 Wed, 15 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730310-remedy-pushes-cell-free-secretome-therapy-for-ipf-into-phase-i Ayele Dilion Mashiah, CEO, Remedy Ayelet Dilion Mashiah, CEO, Remedy Cell Ltd. BioWorld. “The goal is to reset the immune system rather than continuously suppress it, and we believe we have a unique technology to do that.”]]> http://www.bioworld.com/articles/730296 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730296-immune-reset-is-ambition-of-tr1xs-allogenic-tr1-cell-therapy Cell therapy illustration http://www.bioworld.com/articles/730295 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730295-cortec-prepares-to-implant-bci-tech-into-third-stroke-patient Cortec BCI Implant system Cortec Brain Interchange, brain-computer interface (BCI) system. Credit: Cortec GmbH Synox Therapeutics Ltd. is preparing to file for FDA approval of emactuzumab in treating tenosynovial giant cell tumor (TGCT), after announcing positive top-line phase III results.

]]> http://www.bioworld.com/articles/730281 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730281-synox-en-route-to-approval-on-positive-phase-iii-for-tgct Illustration of knee joint, giant cell tumor of bone http://www.bioworld.com/articles/730280 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730280-spyres-spy-001-induces-better-outcomes-in-ulcerative-colitis Ulcerative colitis http://www.bioworld.com/articles/730278 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730278-mrd-word-heard-loud-clear-in-allogene-lbcl-cema-cel-phase-ii Art concept for hematologic cancer http://www.bioworld.com/articles/730277 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730277-revolutions-daraxonrasib-nails-endpoints-in-pancreatic-cancer-trial 3D pancreas illustration http://www.bioworld.com/articles/730134 Tue, 07 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730134-amplia-halts-enrollment-in-phase-ii-pancreatic-cancer-trial Illustration of cancer in the pancreas http://www.bioworld.com/articles/730204 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730204-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute http://www.bioworld.com/articles/730072 Thu, 02 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730072-oral-roid-void-in-ppd-lipocine-mini-bike-may-have-wheels Tired mother holding newborn http://www.bioworld.com/articles/729980 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729980-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute http://www.bioworld.com/articles/729979 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729979-assay-what-eyes-on-pepgens-dm1-phase-ii Limb exam http://www.bioworld.com/articles/730089 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730089-innovents-ibi-302-meets-phase-iii-endpoints-in-neovascular-amd Woman taking Amsler grid eye exam